Key result
Postdischarge thromboprophylaxis was associated with a lower risk of short-term mortality (HR 0.34) compared to no thromboprophylaxis in elderly patients after hip- or knee-replacement surgery.
Why the study?
Does postdischarge thromboprophylaxis reduce short-term mortality in elderly patients discharged home after hip- or knee-replacement surgery?
Cohort (n=10,744)
Yes
Does postdischarge thromboprophylaxis reduce short-term mortality in elderly patients discharged home after hip- or knee-replacement surgery?
Hazard Ratio: 0.34 (95% CI 0.2–0.57)
Postdischarge thromboprophylaxis is underutilized in elderly patients following hip or knee replacement, but its use is associated with a significantly lower risk of short-term mortality.
Authors
No takes yet. Share an insight, caveat, or question.
Should not yet change practice; leaves open whether thromboprophylaxis reduces mortality in randomized trials of elderly arthroplasty patients.
Rahme et al. (2008) conducted a cohort in Hip- or knee-replacement surgery (n=10,744). Postdischarge thromboprophylaxis vs. No postdischarge thromboprophylaxis was evaluated on Short-term mortality (death within 3 months of discharge) (HR 0.34, 95% CI 0.20-0.57). Postdischarge thromboprophylaxis was associated with a lower risk of short-term mortality (HR 0.34) compared to no thromboprophylaxis in elderly patients after hip- or knee-replacement surgery.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: